European group to monitor the drug is recommended to combat the use of drugs for obesity and Rimonabant Acomplia, as they cause severe psychological problems and even increase the risk of suicide to abandon, reports the BBC. Representatives of the European Medicines Agency (EMEA) said that it is necessary to the promotion of these products for as long as it was clearly not suspend its effects on the human psyche. Patients should not take the medication abruptly interrupt his treatment, they should discuss this with your doctor, experts say. In the UK, about 97 thousand people are overweight or obese. Over 20 thousand people at the time, one of these drugs. Taking the drug rimonabant was approved by the EMEA in June. In July last year, already a warning of the EMEA, can cause depression and mental health problems Acomplia character has received. Experts also recommend not to prescribe these drugs to people with symptoms of depression or taking antidepressants. The second study showed that increasing the intake of rimonabant the risk of mental disorders compared with placebo twice. According to researchers in the period from June to August 2008, five cases of suicide in patients who reported in the experiment and drugs, compared with a case of suicide in the control group. Experts plan further studies on the influence of drugs to combat obesity.
No comments:
Post a Comment